Correll C C, Edwards P A
Department of Biological Chemistry, UCLA School of Medicine 90024.
J Biol Chem. 1994 Jan 7;269(1):633-8.
The microsomal enzyme 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase is subject to rapid degradation when cells are incubated with sterols or mevalonic acid (MVA). It has been shown that this rapid degradation is dependent upon both a sterol and another MVA-derived metabolite (Nakanishi, M., Goldstein, J. L., and Brown, M. S. (1988) J. Biol. Chem. 258, 8929-8937). In the current study, inhibitors of the isoprene biosynthetic pathway were used to define further this mevalonic acid derivative involved in the accelerated degradation of HMG-CoA reductase. The accelerated degradation of HMG-CoA reductase in met-18b-2 cells, which is induced by the addition of MVA, was inhibited by the presence of the squalene synthase inhibitor, zaragozic acid/squalestatin, or the squalene epoxidase inhibitor, NB-598. Accelerated degradation of HMG-CoA reductase was observed when NB-598-treated cells were incubated with both MVA and sterols. In contrast, the addition of MVA and sterols to zaragozic acid/squalestatin-treated cells did not result in rapid enzyme degradation. This MVA- and sterol-dependent degradation of HMG-CoA reductase persisted in cells permeabilized with reduced streptolysin O. Finally, the selective degradation of HMG-CoA reductase was also observed in rat hepatic microsomes incubated in vitro in the absence of ATP and cytosol. We conclude that the MVA-derived component that is required for the accelerated degradation of HMG-CoA reductase is derived from farnesyl disphosphate and/or squalene in the isoprenoid biosynthetic pathway. We propose that this component has a permissive effect and does not, by itself, induce the degradation of HMG-CoA reductase. We also conclude that the degradation of HMG-CoA occurs in the endoplasmic reticulum, and, once the degradation of HMG-CoA reductase has been initiated by MVA and sterols, all necessary components for the continued degradation of HMG-CoA reductase reside in the endoplasmic reticulum.
当细胞与固醇或甲羟戊酸(MVA)一起孵育时,微粒体酶3-羟基-3-甲基戊二酰辅酶A(HMG-CoA)还原酶会迅速降解。研究表明,这种快速降解依赖于固醇和另一种MVA衍生的代谢物(中谷,M.,戈尔茨坦,J.L.,和布朗,M.S.(1988年)《生物化学杂志》258,8929 - 8937)。在本研究中,异戊二烯生物合成途径的抑制剂被用于进一步确定这种参与HMG-CoA还原酶加速降解的甲羟戊酸衍生物。甲羟戊酸合酶抑制剂扎戈齐酸/鲨他汀或鲨烯环氧酶抑制剂NB - 598的存在抑制了met - 18b - 2细胞中因添加MVA而诱导的HMG-CoA还原酶的加速降解。当用NB - 598处理的细胞与MVA和固醇一起孵育时,观察到HMG-CoA还原酶的加速降解。相反,向用扎戈齐酸/鲨他汀处理的细胞中添加MVA和固醇并不会导致酶的快速降解。HMG-CoA还原酶的这种依赖于MVA和固醇的降解在经降低浓度的链球菌溶血素O通透处理的细胞中仍然存在。最后,在体外无ATP和胞质溶胶的条件下孵育的大鼠肝微粒体中也观察到了HMG-CoA还原酶的选择性降解。我们得出结论,HMG-CoA还原酶加速降解所需的MVA衍生成分来自类异戊二烯生物合成途径中的法呢基二磷酸和/或鲨烯。我们提出该成分具有允许作用,其本身不会诱导HMG-CoA还原酶的降解。我们还得出结论,HMG-CoA的降解发生在内质网中,并且一旦HMG-CoA还原酶的降解由MVA和固醇启动,HMG-CoA还原酶持续降解所需的所有必要成分都存在于内质网中。